Incyte said on Monday its experimental drug has met the main goal in two separate late-stage studies testing it in patients with an inflammatory skin condition called hidradenitis suppurativa.
Urethral syndrome causes spasms in the urethra, pain during urination, and the frequent urge to pee. Learn why treatment may require a specialist.